{"parse":{"title":"Global Vaccines","pageid":18662925,"revid":831096897,"text":{"*":"<div class=\"mw-parser-output\"><p><b>Global Vaccines, Inc</b> is a <a href=\"/wiki/Non-profit\" class=\"mw-redirect\" title=\"Non-profit\">non-profit</a> company set up to design and develop affordable <a href=\"/wiki/Vaccine\" title=\"Vaccine\">vaccines</a> for people in poor countries.\n</p>\n<h2><span class=\"mw-headline\" id=\"Origins\">Origins</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Global_Vaccines&amp;action=edit&amp;section=1\" title=\"Edit section: Origins\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In 2006, Robert E. Johnston, Ph.D. and Clayton W. Beard, Ph.D., opened the doors of Global Vaccines, Inc (GVI), a not-for-profit company, spinning out from the <a href=\"/wiki/University_of_North_Carolina_at_Chapel_Hill\" title=\"University of North Carolina at Chapel Hill\">University of North Carolina at Chapel Hill</a>, in order to develop new vaccines free from the limitations of high profit-margin requirements. The company develops platform <a href=\"/wiki/Vaccine\" title=\"Vaccine\">vaccine</a> technologies that can be applied to a broad spectrum of disease targets selected on the basis of global public health needs rather than market potential. It is located in the <a href=\"/wiki/Research_Triangle_Park\" title=\"Research Triangle Park\">Research Triangle Park</a> in <a href=\"/wiki/North_Carolina\" title=\"North Carolina\">North Carolina</a>.\n</p><p>In several preclinical trials, Global Vaccines' novel technologies have already shown remarkable promise across a range of <a rel=\"nofollow\" class=\"external text\" href=\"http://www.globalvaccines.org/content/disease+targets+and+vaccine+programs/19610\">disease targets.</a><sup id=\"cite_ref-aVRP/Fluzone_1-0\" class=\"reference\"><a href=\"#cite_note-aVRP/Fluzone-1\">&#91;1&#93;</a></sup>\n<sup id=\"cite_ref-alphavirus/norovirus_2-0\" class=\"reference\"><a href=\"#cite_note-alphavirus/norovirus-2\">&#91;2&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Global_Vaccines&amp;action=edit&amp;section=2\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p><a rel=\"nofollow\" class=\"external text\" href=\"http://www.globalvaccines.org/content/primary+technology+publications+by+gvi/19611\">Primary technology publications from GVI</a>\n</p>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-aVRP/Fluzone-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-aVRP/Fluzone_1-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Carroll TD, Matzinger SR, Barro M, Fritts L, McChesney MB, Miller CJ, Johnston RE (2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3026063\">\"Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone\u00ae in rhesus macaques\"</a>. <i>Vaccine</i>. <b>29</b> (5): 931\u2013940. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.vaccine.2010.11.024\">10.1016/j.vaccine.2010.11.024</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3026063\">3026063</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21111777\">21111777</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Vaccine&amp;rft.atitle=Alphavirus+replicon-based+adjuvants+enhance+the+immunogenicity+and+effectiveness+of+Fluzone%C2%AE+in+rhesus+macaques&amp;rft.volume=29&amp;rft.issue=5&amp;rft.pages=931-940&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3026063&amp;rft_id=info%3Apmid%2F21111777&amp;rft_id=info%3Adoi%2F10.1016%2Fj.vaccine.2010.11.024&amp;rft.aulast=Carroll&amp;rft.aufirst=TD&amp;rft.au=Matzinger%2C+SR&amp;rft.au=Barro%2C+M&amp;rft.au=Fritts%2C+L&amp;rft.au=McChesney%2C+MB&amp;rft.au=Miller%2C+CJ&amp;rft.au=Johnston%2C+RE&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3026063&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlobal+Vaccines\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-alphavirus/norovirus-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-alphavirus/norovirus_2-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">LoBue AD, Thompson JM, Lindesmith L, Johnston RE, Baric RS (2009). <a rel=\"nofollow\" class=\"external text\" href=\"http://jvi.asm.org/content/83/7/3212.long\">\"Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge\"</a>. <i>J. Virol</i>. <b>83</b> (7): 3212\u20133227. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1128/JVI.01650-08\">10.1128/JVI.01650-08</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2655567\">2655567</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19176631\">19176631</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Virol.&amp;rft.atitle=Alphavirus-adjuvanted+norovirus-like+particle+vaccines%3A+heterologous%2C+humoral%2C+and+mucosal+immune+responses+protect+against+murine+norovirus+challenge&amp;rft.volume=83&amp;rft.issue=7&amp;rft.pages=3212-3227&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2655567&amp;rft_id=info%3Apmid%2F19176631&amp;rft_id=info%3Adoi%2F10.1128%2FJVI.01650-08&amp;rft.aulast=LoBue&amp;rft.aufirst=AD&amp;rft.au=Thompson%2C+JM&amp;rft.au=Lindesmith%2C+L&amp;rft.au=Johnston%2C+RE&amp;rft.au=Baric%2C+RS&amp;rft_id=http%3A%2F%2Fjvi.asm.org%2Fcontent%2F83%2F7%2F3212.long&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AGlobal+Vaccines\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Global_Vaccines&amp;action=edit&amp;section=3\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.globalvaccines.org\">www.globalvaccines.org Global Vaccines, Inc</a></li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw1233\nCached time: 20180910033356\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.084 seconds\nReal time usage: 0.105 seconds\nPreprocessor visited node count: 163/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 6357/2097152 bytes\nTemplate argument size: 79/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 4857/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.041/10.000 seconds\nLua memory usage: 1.54 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%   86.928      1 Template:Reflist\n100.00%   86.928      1 -total\n 77.03%   66.958      2 Template:Cite_journal\n  3.12%    2.710      1 Template:Main_other\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:18662925-0!canonical and timestamp 20180910033356 and revision id 831096897\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","*":"Vaccination-related_organizations"}],"links":[{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Non-profit"},{"ns":0,"exists":"","*":"North Carolina"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Research Triangle Park"},{"ns":0,"exists":"","*":"University of North Carolina at Chapel Hill"},{"ns":0,"exists":"","*":"Vaccine"}],"templates":[{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Lock-green.svg"],"externallinks":["//www.ncbi.nlm.nih.gov/pmc/articles/PMC3026063","//doi.org/10.1016/j.vaccine.2010.11.024","//www.ncbi.nlm.nih.gov/pubmed/21111777","http://jvi.asm.org/content/83/7/3212.long","//doi.org/10.1128/JVI.01650-08","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2655567","//www.ncbi.nlm.nih.gov/pubmed/19176631","http://www.globalvaccines.org/content/disease+targets+and+vaccine+programs/19610","http://www.globalvaccines.org/content/primary+technology+publications+by+gvi/19611","http://www.globalvaccines.org"],"sections":[{"toclevel":1,"level":"2","line":"Origins","number":"1","index":"1","fromtitle":"Global_Vaccines","byteoffset":139,"anchor":"Origins"},{"toclevel":1,"level":"2","line":"References","number":"2","index":"2","fromtitle":"Global_Vaccines","byteoffset":1764,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"3","index":"3","fromtitle":"Global_Vaccines","byteoffset":1918,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Global Vaccines","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q5570750"}]}}